ADV P8Alternative Names: ADV-P8
Latest Information Update: 20 Apr 2012
At a glance
- Originator AdvanCell
- Developer Advancell
- Class Antidepressants
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 20 Apr 2012 No development reported - Phase-II for Major depressive disorder in Spain (unspecified route)
- 12 Jan 2009 Phase-II clinical trials in Depression in Spain (unspecified route)